An agonist activates a receptor, which is a cellular target that responds to chemical signals
Meaning Among adults with overweight or obesity completing a 20-week run-in period, maintaining treatment with subcutaneous semaglutide compared with switching to placebo resulted in continued weight loss
Hormonal alterations Since stress has been described as a potential trigger for ME/CFS (422) and cause of symptom flare-ups (423, 424), it is likely that the HPA axis- the neurobiological stress system- may be implicated in ME/CFS (53, 425, 426), as well as abnormalities in growth hormone (GH) secretion and dysfunctional adrenergic metabolism (255)
Rammohan A, Bhaskar BV, Venkateswarlu N, Gu W, Zyryanov GV
So I wouldnt expect compounded BPC-157 to be legal in the next few months